Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

SLDB Financial Statements and Analysis

NASDAQ : SLDB

Solid Biosciences Inc.

$5.78
-0.22-3.67%
At Close 4:00 PM
$6.12
0.34+5.88%
Pre-Market 07:59 PM
63.06
BESG ScoreESG Rating

SLDB FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

SLDB Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue01.235M327.00K587.00K588.00K
gross profit0-1.235M-327.00K-587.00K-588.00K
gross profit ratio00000
research and development expenses27.327M19.461M18.873M15.453M16.702M
general and administrative expenses7.855M8.327M7.989M6.812M6.412M
selling and marketing expenses00-327.00K-587.00K0
selling general and administrative expenses7.855M8.327M7.662M6.225M6.412M
other expenses0239.00K3.00K270.00K278.00K
operating expenses35.182M27.788M26.535M21.678M23.114M
cost and expenses35.182M27.788M26.862M22.265M23.114M
interest income2.328M2.565M2.651M1.659M1.856M
interest expense82.00K88.00K95.00K00
depreciation and amortization405.00K1.235M327.00K587.00K588.00K
ebitda-35.182M-23.749M-23.881M-21.678M-23.114M
ebitda ratio00000
operating income-35.182M-27.788M-26.862M-22.265M-23.114M
operating income ratio00000
total other income expenses net2.457M2.716M2.559M1.929M2.134M
income before tax-32.725M-25.072M-24.303M-20.336M-20.98M
income before tax ratio00000
income tax expense0-1.235M283.724K0-588.00K
net income-32.725M-25.072M-24.303M-20.336M-20.98M
net income ratio00000
eps-0.79-0.61-0.64-1.00-1.05
eps diluted-0.79-0.61-0.64-1.00-1.05
weighted average shs out41.443M40.934M38.155M20.387M20.06M
weighted average shs out dil41.443M40.934M38.155M20.387M20.06M
Graph

SLDB Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents64.394M95.854M117.574M74.015M49.037M
short term investments106.723M94.412M88.492M49.625M93.847M
cash and short term investments171.117M190.266M206.066M123.64M142.884M
net receivables00000
inventory00000
other current assets8.377M7.344M8.126M6.094M2.412M
total current assets179.494M197.61M214.192M129.734M148.346M
property plant equipment net29.926M30.946M32.489M33.163M34.234M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments01.91M1.833M1.833M1.833M
tax assets00000
other non current assets2.406M514.999K175.00K209.00K315.00K
total non current assets32.332M33.371M34.497M35.205M36.382M
other assets01.001.001.000
total assets211.826M230.981M248.689M164.939M184.728M
account payables3.458M2.521M1.73M2.032M1.898M
short term debt2.769M4.498M2.19M2.324M2.29M
tax payables00000
deferred revenue000011.466M
other current liabilities16.627M7.669M10.419M10.161M162.00K
total current liabilities22.854M14.688M14.339M14.517M15.816M
long term debt21.95M23.048M23.626M23.941M24.551M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00000
total non current liabilities21.95M23.048M23.626M23.941M24.551M
other liabilities01.00000
capital lease obligations24.719M23.048M23.626M23.941M26.841M
total liabilities44.804M37.736M37.965M38.458M40.367M
preferred stock00000
common stock39.00K39.00K38.00K20.00K20.00K
retained earnings-740.853M-708.128M-683.056M-658.753M-638.417M
accumulated other comprehensive income loss116.00K-15.00K-4.00K15.00K2.00K
other total stockholders equity907.72M901.349M893.746M785.199M782.756M
total stockholders equity167.022M193.245M210.724M126.481M144.361M
total equity167.022M193.245M210.724M126.481M144.361M
total liabilities and stockholders equity211.826M230.981M248.689M164.939M184.728M
minority interest00000
total investments106.723M96.322M90.325M51.458M93.847M
total debt24.719M25.297M25.816M26.265M26.841M
net debt-39.675M-70.557M-91.758M-47.75M-22.196M
Graph

SLDB Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-09-302024-06-302024-03-312023-12-312023-09-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax000-2.978M-20.339M
stock based compensation2.995M2.092M1.611M1.938M1.625M
change in working capital2.115M78.00K-2.193M-1.861M1.854M
accounts receivables00000
inventory00000
accounts payables918.00K1.068M-596.00K134.00K-929.00K
other working capital2.587M-990.00K-1.597M-1.995M2.783M
other non cash items8.258M3.694M2.227M1.827M19.355M
net cash provided by operating activities-23.708M-21.467M-25.192M-20.823M-17.897M
investments in property plant and equipment-15.00K-286.00K-149.00K-90.00K-383.00K
acquisitions net000024.252M
purchases of investments-85.472M-20.19M-83.346M-14.614M-34.252M
sales maturities of investments74.50M15.30M45.00M60.00M10.00M
other investing activites005.00K0-24.252M
net cash used for investing activites-10.987M-5.176M-38.49M45.296M-24.635M
debt repayment-120.00K-225.00K000
common stock issued-8.574M5.366M112.066M435.00K2.539M
common stock repurchased000078.00K
dividends paid00000
other financing activites11.95M-141.00K-4.825M70.00K-2.617M
net cash used provided by financing activities3.256M5.00M107.241M505.00K2.617M
effect of forex changes on cash000023.177M
net change in cash-29.529M-21.72M43.559M24.978M-42.532M
cash at end of period66.325M95.854M117.574M74.015M50.87M
cash at beginning of period95.854M117.574M74.015M49.037M93.402M
operating cashflow-23.708M-21.467M-25.192M-20.823M-17.897M
capital expenditure-15.00K-286.00K-149.00K-90.00K-383.00K
free cash flow-23.723M-21.753M-25.341M-20.913M-18.28M
Graph

Frequently Asked Questions

How did Solid Biosciences Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, SLDB generated $0.00 in revenue last quarter, while its costs came in at $0.00.

Last quarter, how much Gross Profit did Solid Biosciences Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Solid Biosciences Inc. reported a $0.00 Gross Profit for the quarter ended Sep 30, 2024.

Have SLDB's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. SLDB incurred $35.18M worth of Operating Expenses, while it generated -$35.18M worth of Operating Income.

How much Net Income has SLDB posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Solid Biosciences Inc., the company generated -$32.73M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Solid Biosciences Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Solid Biosciences Inc. as of the end of the last quarter was $64.39M.

What are SLDB's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, SLDB had Total Net Receivables of $0.00.

In terms of Total Assets and Current Assets, where did Solid Biosciences Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of SLDB were $179.49M, while the Total Assets stand at $211.83M.

As of the last quarter, how much Total Debt did Solid Biosciences Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of SLDB's debt was $24.72M at the end of the last quarter.

What were SLDB's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, SLDB reported total liabilities of $44.80M.

How much did SLDB's Working Capital change over the last quarter?

Working Capital Change for SLDB was $2.12M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

SLDB generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. SLDB generated -$23.71M of Cash from Operating Activities during its recently reported quarter.

What was SLDB's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. SLDB reported a -$29.53M Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph